Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Impact of body mass index on plasma N-terminal ProB-type natriuretic peptides in Chinese atrial fibrillation patients without heart failure.

Zheng LH, Wu LM, Yao Y, Chen WS, Bao JR, Huang W, Shi R, Zhang KJ, Zhang S.

PLoS One. 2014 Aug 21;9(8):e105249. doi: 10.1371/journal.pone.0105249. eCollection 2014.

2.

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr.

Am Heart J. 2005 Apr;149(4):744-50.

PMID:
15990762
3.

Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.

Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL Jr.

Arch Intern Med. 2007 Feb 26;167(4):400-7.

PMID:
17325303
4.

Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.

Eckstein J, Potocki M, Murray K, Breidthardt T, Ziller R, Mosimann T, Klima T, Hoeller R, Moehring B, Sou SM, Rubini Gimenez M, Morgenthaler NG, Mueller C.

Heart. 2012 Oct;98(20):1518-22. Epub 2012 Aug 3.

PMID:
22865868
5.
6.

[Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].

Pokorná V, Jurkovicová O, Kaluzay J, Stecová A, Pont'uch P.

Vnitr Lek. 2010 Aug;56(8):788-94. Slovak.

PMID:
20845610
7.

Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.

Corell P, Gustafsson F, Kistorp C, Madsen LH, Schou M, Hildebrandt P.

Int J Cardiol. 2007 May 2;117(3):395-402. Epub 2006 Aug 17.

PMID:
16919342
8.
9.

Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.

Christenson RH, Azzazy HM, Duh SH, Maynard S, Seliger SL, Defilippi CR.

Clin Chem. 2010 Apr;56(4):633-41. doi: 10.1373/clinchem.2009.129742. Epub 2010 Feb 18.

10.

The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.

Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG.

Eur Heart J. 2006 Oct;27(19):2353-61. Epub 2006 Sep 4.

PMID:
16952921
11.

Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.

Nadrowski P, Chudek J, Grodzicki T, Mossakowska M, Skrzypek M, Wiecek A, Zdrojewski T, Kozakiewicz K.

Exp Gerontol. 2013 Sep;48(9):852-7. doi: 10.1016/j.exger.2013.05.060. Epub 2013 Jun 13.

PMID:
23770107
12.

Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure.

Jug B, Sebestjen M, Sabovic M, Pohar M, Keber I.

Wien Klin Wochenschr. 2009;121(21-22):700-6. doi: 10.1007/s00508-009-1269-5.

PMID:
19998011
13.

Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.

Dixen U, Ravn L, Soeby-Rasmussen C, Paulsen AW, Parner J, Frandsen E, Jensen GB.

Cardiology. 2007;108(1):35-9. Epub 2006 Sep 12.

PMID:
16968988
14.
15.

Associations between circulating N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) and adiponectin concentrations depend on obesity level in female adolescents: gender dimorphic findings.

Pervanidou P, Margeli A, Akalestos A, Sakka S, Kanaka-Gantenbein C, Papassotiriou I, Chrousos GP.

Horm Metab Res. 2009 Nov;41(11):829-33. doi: 10.1055/s-0029-1233459. Epub 2009 Aug 10.

PMID:
19670155
16.

Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation.

Nilsson B, Goetze JP, Chen X, Pehrson S, Svendsen JH.

Scand J Clin Lab Invest. 2009;69(8):843-50. doi: 10.3109/00365510903318209.

PMID:
19929271
17.

Impact of atrial fibrillation on NT-proBNP levels in a 75-year-old population.

Ulimoen SR, Enger S, Tveit A.

Scand J Clin Lab Invest. 2009;69(5):579-84. doi: 10.1080/00365510902853305.

PMID:
19391062
18.

Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.

Hwang HJ, Son JW, Nam BH, Joung B, Lee B, Kim JB, Lee MH, Jang Y, Chung N, Shim WH, Cho SY, Kim SS.

Clin Res Cardiol. 2009 Apr;98(4):213-8. doi: 10.1007/s00392-009-0744-3. Epub 2009 Feb 19.

PMID:
19229464
19.

NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.

Fan J, Cao H, Su L, Ling Z, Liu Z, Lan X, Xu Y, Chen W, Yin Y.

J Interv Card Electrophysiol. 2012 Jan;33(1):93-100. doi: 10.1007/s10840-011-9606-9. Epub 2011 Sep 21.

PMID:
21938519
20.

Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.

Rienstra M, Van Gelder IC, Van den Berg MP, Boomsma F, Van Veldhuisen DJ.

Europace. 2006 Jul;8(7):482-7.

PMID:
16798760

Supplemental Content

Support Center